12 Health Care Stocks Moving In Thursday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Thursday's intraday session, several healthcare stocks experienced significant movements. Bionomics (BNOX), Baudax Bio (BXRX), Femasys (FEMY), Axcella Health (AXLA), Organogenesis Hldgs (ORGO), and Aytu BioPharma (AYTU) saw increases, with Bionomics leading with a 261.4% rise. On the other hand, Brainstorm Cell (BCLI), Renalytix (RNLX), Sharps Technology (STSS), ACADIA Pharmaceuticals (ACAD), Avalo Therapeutics (AVTX), and Biophytis (BPTS) experienced decreases, with Brainstorm Cell falling by 55.3%.
September 28, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ACADIA Pharmaceuticals shares decreased by 13.9% to $22.02.
The substantial decrease in ACADIA Pharmaceuticals' share price is expected to have a negative impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Avalo Therapeutics shares decreased by 13.76% to $0.15.
The significant decrease in Avalo Therapeutics' share price is likely to have a negative impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Brainstorm Cell stock fell 55.3% to $0.19 during Thursday's regular session.
The significant decrease in Brainstorm Cell's stock price is likely to have a negative impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Biophytis shares fell 13.73% to $1.26.
The substantial decrease in Biophytis' share price is expected to have a negative impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Renalytix shares fell 20.16% to $1.56.
The substantial decrease in Renalytix's share price is expected to have a negative impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Sharps Technology shares decreased by 15.79% to $0.48.
The significant decrease in Sharps Technology's share price is likely to have a negative impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Axcella Health shares increased by 26.62% to $8.75.
The substantial rise in Axcella Health's share price is expected to have a positive impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Aytu BioPharma stock moved upwards by 25.52% to $2.41.
The substantial increase in Aytu BioPharma's stock price is expected to have a positive impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Bionomics stock increased by 261.4% to $3.56 during Thursday's regular session.
The significant increase in Bionomics' stock price is likely to have a positive impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Baudax Bio stock rose 74.26% to $0.52.
The substantial rise in Baudax Bio's stock price is expected to have a positive impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Femasys shares increased by 41.45% to $1.57.
The significant increase in Femasys' share price is likely to have a positive impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Organogenesis Hldgs stock rose 25.84% to $3.33.
The significant rise in Organogenesis Hldgs' stock price is likely to have a positive impact on its short-term performance.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100